Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

4 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Triamcinolone Acetonide cream

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Completed cGMP deviation Direct Rx NDC 72189-330-80 D-1535-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-130-01 D-0793-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-129-01 D-0792-2022

Recalls by year